相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome
L. A. Henry et al.
ONCOGENE (2011)
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Simon A. Hawley et al.
CELL METABOLISM (2010)
HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma
Colin A. Purdie et al.
HISTOPATHOLOGY (2010)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Histological evaluation of AMPK signalling in primary breast cancer
Sirwan M. Hadad et al.
BMC CANCER (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Targeting AMPK: A new therapeutic opportunity in breast cancer
Sirwan M. Hadad et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
A candidate molecular signature associated with tamoxifen failure in primary breast cancer
Julie A. Vendrell et al.
BREAST CANCER RESEARCH (2008)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice
Young Hun Choi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes
E Zmuda-Trzebiatowska et al.
CELLULAR SIGNALLING (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
β-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology
L Härndahl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
AS Marsin et al.
CURRENT BIOLOGY (2000)
分享论文
